Literature DB >> 8219116

[Initial findings using dynamic magnetic resonance tomography in the diagnosis of inflammatory diseases of the sacroiliac joint].

M Bollow1, H König, C Hoffmann, A Schilling, K J Wolf.   

Abstract

Up to now 42 patients with clinically suspected diagnosis of sacroiliitis (including 19 patients with confirmed spondylitis ankylosans) and 12 healthy volunteers were examined via magnetic resonance tomography. In oblique sections parallel to the plane of the sacrum the signal intensity patterns from normal and pathological tissues of the sacroiliac articulations were evaluated by plain T1-weighted spin-echo sequences and T2*-weighted FLASH sequences. In addition we used a dynamic FLASH measurement following intravenous application of gadolinium-DTPA for quantitative calculation of signal-time courses. This method has proved to be capable of definitely differentiating normal findings of sacroiliac articulations from inflammatory changes (p = 0.0001) and also enables quantification of the inflammatory activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8219116     DOI: 10.1055/s-2008-1032772

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  4 in total

1.  NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-alpha monoclonal antibody therapy.

Authors:  D Kalden-Nemeth; J Grebmeier; C Antoni; B Manger; F Wolf; J R Kalden
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

Review 2.  [Grading sacroiliitis with emphasis on MRT-imaging].

Authors:  A G Jurik; N Egund
Journal:  Radiologe       Date:  2004-03       Impact factor: 0.635

Review 3.  [Magnetic resonance tomography of sacroiliitis: anatomy, histological pathology, MR-morphology, and grading].

Authors:  K G A Hermann; J Braun; T Fischer; H Reisshauer; M Bollow
Journal:  Radiologe       Date:  2004-03       Impact factor: 0.635

Review 4.  A systematic critical review on MRI in spondyloarthritis.

Authors:  Bodil Arnbak; Charlotte Leboeuf-Yde; Tue Secher Jensen
Journal:  Arthritis Res Ther       Date:  2012-03-09       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.